This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Editorial

Electroconvulsive Therapy Update: Recognizing and Treating Psychotic Depression

Max Fink, MD

Published: March 15, 2003

Article Abstract
Editorial: Electroconvulsive Therapy Update: Recognizing and Treating Psychotic Depression.

"Therapy resistance" is an increasing burden in patient care. Despite our many medications and psychotherapies, we see an increasingly larger frustrated population of therapists and families as more patients fail to respond to treatment and are labeled "pharmacotherapy-resistant." The frustration is all the worse because effective treatment is available for some diagnoses when properly made. Psychotic depression is one such treatable condition that is difficult to recognize.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 64

Quick Links: Depression (MDD) , Electroconvulsive Therapy

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...